M
MGX
Metagenomi Therapeutics, Inc
1.400
+0.020+1.45%Closed16:10 04/13 EDT
OPEN/PREV CLOSE1.380/1.380
TODAY RANGE1.380-1.435
VOL130.33K
MARKET CAP52.67M
52 WEEK RANGE1.250-3.950
AVG VOL (3M)243.18K
% TURNOVER0.35%
TURNOVER0
P/E (TTM)-0.5935
% RANGE3.99%
EPS(TTM)-2.3588
P/E(FORWARD)-0.6625
P/B0.3321
BVPS4.216
DIVIDEND--
P/S2.089
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP37.89M
SHARES OUTSTANDING37.62M
NEXT EARNINGS05/08-05/20
FREE FLOAT27.06M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·03/06 14:36
Buy These 3 Best Stocks Now, According to Top Wall Street Analysts, 3/6/2026
TipRanks·03/06 00:16
Chardan Capital Remains a Buy on Metagenomi, Inc. (MGX)
NASDAQ·03/05 22:30
Metagenomi Therapeutics (MGX) Reports Q4 Loss, Misses Revenue Estimates
Seeking Alpha·03/05 22:00
Metagenomi GAAP EPS of -$2.36 in-line, revenue of $25.2M misses by $3.43M
Benzinga·03/05 21:14
Metagenomi Therapeutics Q4 Earnings Assessment
Dow Jones·03/05 21:12
*Metagenomi Therapeutics 2025 Collaboration Rev $25.2M
Dow Jones·03/05 21:12
*Metagenomi Therapeutics 2025 Loss/Shr $2.36
Dow Jones·03/05 21:05
Press Release: Metagenomi Therapeutics Reports -2-
TipRanks·01/12 14:57
Metagenomi Therapeutics Rebrands to Emphasize Therapeutic Focus
TipRanks·01/12 13:35
Metagenomi to submit IND in Q4 2026 to advance MGX-001 into first human studies
Same Industry
Name/Symbol
Change%
Price